Replies to post #54421 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Thanks for answering. Your answers are correct imho, and the one you skipped has perhaps the most interesting answer.

1. Was Dr. Bosch positively or negatively surprised by the survival performance for rapid progressors in the information group? Positively
Bonus question: Why was he surprised? skip Do Not Know

"It's a bit of an unexpected data set, if I may be so honest. This is for patients....that we originally felt were ineligible for the trial, because they were in too severe of a disease state to be able to respond to immune therapy, and the results took us a little bit by surprise." -- Dr. Bosch